What Key Growth Drivers Are Shaping The Therapeutic Plasma Exchange Market Forecast Toward $2.25 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Therapeutic Plasma Exchange Market Today And What Is Its Future Size?
The size of the therapeutic plasma exchange market has seen significant expansion in the past few years. The market, currently valued at $1.47 billion in 2024, is projected to increase to $1.61 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.5%. This remarkable growth during the historic period is due to the rise of immunological diseases, advancing technologies, heightened awareness and education, widened indications, and a more sophisticated comprehension of the pathophysiology.
Over the coming years, a robust growth in the size of the therapeutic plasma exchange market is anticipated. By 2029, it’s anticipated to reach $2.25 billion, witnessing a compound annual growth rate (CAGR) of 8.7%. The factors contributing to the growth during the forecast period include an escalating elderly population, established clinical proof and protocols, regulatory norms, hospital facilities and healthcare investments, overall healthcare spending, and reimbursement policies. The key trends projected to shape the market during the forecast period involve customized therapy solutions, the incorporation of automation, cooperative ventures, and the integration of telemedicine.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp
Which Demand Drivers Are Strengthening The Therapeutic Plasma Exchange Market?
Anticipated expansion in the therapeutic plasma exchange market is largely due to an increase in blood-related diseases. Blood disorders have a direct impact on blood and blood-forming tissues, like bone marrow, lymph nodes, and the spleen. An upsurge of such disorders can be attributed to genetic predispositions, environmental factors, and changes in lifestyle. Therapeutic plasma exchange (TPE) serves significant in blood-related disorders as it helps eliminate harmful substances from the plasma—this includes autoantibodies found in autoimmune hemolytic anemia or immune compounds in thrombotic thrombocytopenic purpura—which, in turn, lessens the severity of the disease and enhances patient outcomes. As an example, the Leukemia and Lymphoma Society based in the US projected in August 2023 that there would be a 2.3% rise in myeloma diagnoses from 2021 to 2023, where figures are likely to shift from 34,920 to 35,730 diagnoses respectively. Therefore, with the escalating prevalence of blood-related disorders, it is clear that growth in the therapeutic plasma exchange market will significantly accelerate.
Which Segment Accounts For The Largest Share In The Therapeutic Plasma Exchange Market?
The therapeutic plasma exchangemarket covered in this report is segmented –
1) By Type: Therapeutic Plasma Exchange (TPE); Double Filtered Plasmapheresis (DFPP)
2) By Indication: Neurological Disorders; Hematological Disorders; Renal Disorders; Metabolic Disorders; Other Indications
3) By Technology: Centrifugation; Membrane Separation
4) By End User: Blood Collection Centers; Hospitals And Clinics; Transfusion Centers; Other End Users
Subsegments:
1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe; Automated Tpe
2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp; Multi-Stage Dfpp
Which Disruptive Trends Are Driving Change Across The Therapeutic Plasma Exchange Market?
Leading firms in the therapeutic plasma exchange market, such as Terumo Blood and Cell Technologies and Eliaz Therapeutics Inc., are employing strategic partnerships as a method of bolstering technological integration and expanding their market footprint. This type of strategic alliance commonly sees two or more companies combining their resources, expertise and joint efforts to accomplish shared targets or objectives. An illustration of this is Terumo’s recent partnership with Eliaz Therapeutics in July 2022. This collaboration focused on finding solutions to acute kidney injury (AKI) and sepsis-induced AKI (S-AKI) by selectively eliminating the inflammatory protein Gal-3 from blood plasma. Given the high mortality rate of AKI, the partnership is set to explore new lines of treatment using Terumo’s Spectra Optia Apheresis System and ETI’s XGal-3 column. Initial research is being conducted on large animals, with the intention to move to human trials. Terumo, an innovator in the field of therapeutic apheresis, has a history of working on projects that seek to address issues like triple-negative breast cancer and COVID-19.
Which Companies Hold A Competitive Edge In The 1143 Market?
Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report
Which Region Is Forecasted To Lead The Therapeutic Plasma Exchange Market In The Coming Years?
North America was the largest region in the therapeutic plasma exchange market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15683&type=smp
Browse Through More Reports Similar to the Global Therapeutic Plasma Exchange Market 2025, By The Business Research Company
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Respiratory Devices And Equipment Therapeutic Global Market Report 2025
Antisense And Rnai Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
